Evidence map›Paper›PMID 38190378›Full record

ArticlePLoS pathogens2024

Exosomes derived from bladder epithelial cells infected with uropathogenic Escherichia coli increase the severity of urinary tract infections (UTIs) by impairing macrophage function.

Zihao Wang, Ziming Jiang, Yu Zhang, Congwei Wang, Zhaoyang Liu, Zhankui Jia, Sudhanshu Bhushan, Jinjian Yang, Zhengguo Zhang

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. IL-17B protects against uropathogenicMicrobiology spectrum · 2026
    Article
  5. Article
  6. Analysis of Human miRNA Derived From Bladder Epithelial Cells Infected With Uropathogenic Escherichia coli.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2026
    Article
  7. Clinical Applications of Extracellular Vesicles: Promises and Pitfalls.International journal of molecular sciences · 2026
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Zihao WangDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Ziming JiangDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Yu ZhangDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Congwei WangDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Zhaoyang LiuDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Zhankui JiaDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Sudhanshu BhushanInstitute of Anatomy and Cell Biology, Unit of Reproductive Biology, Justus-Liebig-University Giessen, Giessen, Germany.
Jinjian YangDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Zhengguo ZhangDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.ORCID 0000-0002-6476-0119
First Affiliated Hospital of Zhengzhou University · CNJustus-Liebig-Universität Gießen · DE

Funding

Medical Science and Technology Project of Henan ProvinceNational Natural Science Foundation of China
6 · The paper itself

Abstract

Uropathogenic Escherichia coli (UPEC) is the primary causative agent of urinary tract infections (UTIs) in humans. Moreover, as one of the most common bacterial pathogens, UPEC imposes a substantial burden on healthcare systems worldwide. Epithelial cells and macrophages are two major components of the innate immune system, which play critical roles in defending the bladder against UPEC invasion. Yet, the routes of communication between these cells during UTI pathogenesis are still not fully understood. In the present study, we investigated the role of membrane-bound nanovesicles (exosomes) in the communication between bladder epithelial cells and macrophages during UPEC infection, using an array of techniques such as flow cytometry, miRNA profiling, RNA sequencing, and western blotting. Moreover, our in vitro findings were validated in a mouse model of UPEC-induced cystitis. We found that UPEC infection induced the bladder epithelial MB49 cell line to secrete large numbers of exosomes (MB49-U-Exo), which were efficiently absorbed by macrophages both in vivo and in vitro. Assimilation of MB49-U-Exo induced macrophages to produce proinflammatory cytokines, including tumor necrosis factor (TNF)α. Exposure of macrophages to MB49-U-Exo reduced their phagocytic activity (by downregulating the expression of phagocytosis-related genes) and increased their rate of apoptosis. Mechanistically, we showed that MB49-U-Exo were enriched in miR-18a-5p, which induced TNFα expression in macrophages by targeting PTEN and activating the MAPK/JNK signaling pathway. Moreover, administration of the exosome secretion inhibitor GW4869 or a TNFα-neutralizing antibody alleviated UPEC-mediated tissue damage in mice with UPEC-induced cystitis by reducing the bacterial burden of the bladder and dampening the associated inflammatory response. Collectively, these findings suggest that MB49-U-Exo regulate macrophage function in a way that exacerbates UPEC-mediated tissue impairment. Thus, targeting exosomal -release or TNFα signaling during UPEC infection may represent promising non-antibiotic strategies for treating UTIs.

Indexed as

CystitisEscherichia coli InfectionsExosomesUrinary Tract InfectionsUropathogenic Escherichia coliAnimalsEpithelial CellsHumansMacrophagesMiceTumor Necrosis Factor-alphaUrinary BladderTumor Necrosis Factor-alpha

Identifiers

PMID38190378
PMCPMC10798623
OpenAlexW4390660521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.